Balogh A - Search Results

1

Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.

Balogh A, Merkel U, Looks A, Vollandt R, Wollina U. Balogh A, et al. Exp Toxicol Pathol. 1998 Sep;50(4-6):397-401. doi: 10.1016/S0940-2993(98)80025-0. Exp Toxicol Pathol. 1998. PMID: 9784014 Clinical Trial.

2

Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.

Balogh A, Merkel U, Looks A, Vollandt R, Wollina U. Balogh A, et al. Skin Pharmacol Appl Skin Physiol. 1998;11(4-5):258-65. doi: 10.1159/000029835. Skin Pharmacol Appl Skin Physiol. 1998. PMID: 9885410 Clinical Trial.

3

[Progressive systemic sclerosis - treatment results of extracorporeal photopheresis].

Wollina U, Oelzner S, Looks A, Hipler UC, Knöll B, Lange D, Balogh A, Merkel U, Hein G, Oelzner P, Uhlemann C, Vogelsang H. Wollina U, et al. Among authors: balogh a. Hautarzt. 1999 Sep;50(9):637-42. doi: 10.1007/s001050050973. Hautarzt. 1999. PMID: 10501679 Review. German.

4

High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.

Kappes UP, Barta U, Merkel U, Balogh A, Elsner P. Kappes UP, et al. Among authors: balogh a. Skin Pharmacol Appl Skin Physiol. 2003 Sep-Oct;16(5):305-12. doi: 10.1159/000072070. Skin Pharmacol Appl Skin Physiol. 2003. PMID: 12907835 Clinical Trial.

5

Can xipamide or tacrolimus inhibit the glucuronidation of mycophenolic acid in rat liver slices?

Balogh A, Merkel U, Müller D. Balogh A, et al. Exp Toxicol Pathol. 2003 Jun;54(5-6):375-9. doi: 10.1078/0940-2993-00273. Exp Toxicol Pathol. 2003. PMID: 12877348

6

Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.

Merkel U, Lindner S, Vollandt R, Sperschneider H, Balogh A. Merkel U, et al. Among authors: balogh a. Int J Clin Pharmacol Ther. 2005 Aug;43(8):379-88. doi: 10.5414/cpp43379. Int J Clin Pharmacol Ther. 2005. PMID: 16119513

7

Intra-individual variability of caffeine elimination in healthy subjects.

Balogh A, Harder S, Vollandt R, Staib AH. Balogh A, et al. Int J Clin Pharmacol Ther Toxicol. 1992 Oct;30(10):383-7. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1304170

8

Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.

Kuhn UD, Kirsch M, Merkel U, Eberhardt AM, Wenda B, Maurer I, Härtter S, Hiemke C, Volz HP, Balogh A. Kuhn UD, et al. Among authors: balogh a. Int J Clin Pharmacol Ther. 2007 Jan;45(1):36-46. doi: 10.5414/cpp45036. Int J Clin Pharmacol Ther. 2007. PMID: 17256449 Clinical Trial.

9

Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?

Kuhn UD, Lupp A, Kostka E, Kühl A, Balogh A, Stein G, Fleck C. Kuhn UD, et al. Among authors: balogh a. Exp Toxicol Pathol. 1998 Sep;50(4-6):484-90. doi: 10.1016/S0940-2993(98)80038-9. Exp Toxicol Pathol. 1998. PMID: 9784027

10

Can grapefruit juice influence ethinylestradiol bioavailability?

Weber A, Jäger R, Börner A, Klinger G, Vollanth R, Matthey K, Balogh A. Weber A, et al. Among authors: balogh a. Contraception. 1996 Jan;53(1):41-7. doi: 10.1016/0010-7824(95)00252-9. Contraception. 1996. PMID: 8631189 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters